Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,659 | 31 | 99.4% |
| Education | $16.26 | 3 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $716.56 | 8 | $0 (2024) |
| Novo Nordisk Inc | $665.79 | 6 | $0 (2022) |
| Amarin Pharma Inc. | $399.98 | 3 | $0 (2019) |
| Amgen Inc. | $243.64 | 2 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $214.64 | 3 | $0 (2022) |
| Abbott Laboratories | $145.19 | 2 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $108.80 | 1 | $0 (2024) |
| PFIZER INC. | $52.20 | 1 | $0 (2018) |
| ABBVIE INC. | $23.71 | 1 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $21.82 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $245.42 | 3 | AstraZeneca Pharmaceuticals LP ($121.76) |
| 2023 | $135.74 | 2 | Amgen Inc. ($121.82) |
| 2022 | $620.96 | 8 | Abbott Laboratories ($145.19) |
| 2021 | $214.26 | 3 | Novo Nordisk Inc ($100.23) |
| 2020 | $117.23 | 1 | Novo Nordisk Inc ($117.23) |
| 2019 | $657.29 | 7 | Amarin Pharma Inc. ($269.96) |
| 2018 | $532.55 | 7 | Novo Nordisk Inc ($323.33) |
| 2017 | $151.82 | 3 | AstraZeneca Pharmaceuticals LP ($130.00) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $108.80 | General |
| Category: DIABETES | ||||||
| 02/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Oncology | ||||||
| 01/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $121.76 | General |
| Category: Respiratory | ||||||
| 05/04/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: Cardiology | ||||||
| 03/28/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: UROLOGY | ||||||
| 08/23/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $84.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/15/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Cardio-renal | ||||||
| 07/22/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Diabetes | ||||||
| 07/14/2022 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: Inflammation | ||||||
| 05/27/2022 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $134.76 | General |
| Category: Structural Heart | ||||||
| 05/19/2022 | Abbott Laboratories | ALINIQ (Device) | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: Core Diagnostics | ||||||
| 05/05/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $107.73 | General |
| Category: Respiratory | ||||||
| 03/23/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Respiratory | ||||||
| 06/02/2021 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Endocrinology | ||||||
| 05/13/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $100.23 | General |
| Category: Diabetes | ||||||
| 02/13/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $117.23 | General |
| Category: Diabetes | ||||||
| 11/19/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $129.10 | General |
| Category: Hypertriglyceridemia | ||||||
| 09/26/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Education | In-kind items and services | $5.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/05/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $126.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/16/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $140.86 | General |
| Category: Hypertriglyceridemia | ||||||
| 02/21/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/14/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $6.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/04/2018 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $130.02 | General |
| Category: Hypertriglyceridemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 413 | 530 | $51,952 | $28,747 |
| 2022 | 14 | 457 | 720 | $78,247 | $41,524 |
| 2021 | 13 | 508 | 748 | $77,217 | $42,596 |
| 2020 | 15 | 567 | 837 | $86,872 | $42,645 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 137 | $17,125 | $7,330 | 42.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 49 | 49 | $8,575 | $5,842 | 68.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 61 | $9,150 | $4,281 | 46.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 14 | 16 | $4,800 | $3,247 | 67.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 38 | 38 | $2,852 | $2,733 | 95.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $2,850 | $1,284 | 45.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 40 | 40 | $1,600 | $1,140 | 71.3% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 53 | 53 | $1,325 | $886.16 | 66.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 51 | 51 | $1,275 | $852.72 | 66.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 14 | 21 | $1,890 | $801.99 | 42.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 26 | 35 | $350.00 | $294.00 | 84.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 16 | $160.00 | $54.56 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 63 | 150 | $18,750 | $7,716 | 41.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 60 | 60 | $10,500 | $7,525 | 71.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 57 | $8,550 | $4,860 | 56.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 22 | 31 | $9,300 | $4,758 | 51.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 12 | 17 | $5,100 | $3,620 | 71.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 25 | 64 | $7,680 | $3,471 | 45.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 33 | 113 | $8,475 | $3,163 | 37.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 31 | 31 | $2,327 | $2,125 | 91.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 12 | 19 | $3,325 | $1,535 | 46.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 35 | 35 | $1,400 | $957.60 | 68.4% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 48 | 48 | $1,200 | $846.18 | 70.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 46 | 46 | $1,150 | $796.49 | 69.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 25 | 36 | $360.00 | $106.17 | 29.5% |
About Dr. Dilip Shah, M.D
Dr. Dilip Shah, M.D is a Internal Medicine healthcare provider based in Alabaster, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588633077.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dilip Shah, M.D has received a total of $2,675 in payments from pharmaceutical and medical device companies, with $245.42 received in 2024. These payments were reported across 34 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,659).
As a Medicare-enrolled provider, Shah has provided services to 1,945 Medicare beneficiaries, totaling 2,835 services with total Medicare billing of $155,513. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Alabaster, AL
- Active Since 03/16/2006
- Last Updated 04/26/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1588633077
Products in Payments
- Vascepa (Drug) $399.98
- FARXIGA (Drug) $387.07
- Ozempic (Drug) $341.56
- XARELTO (Drug) $209.38
- BREZTRI (Drug) $207.73
- MITRACLIP (Device) $134.76
- Rybelsus (Drug) $125.00
- Otezla (Drug) $121.82
- Repatha (Biological) $121.82
- AIRSUPRA (Drug) $121.76
- JARDIANCE (Drug) $108.80
- RYBELSUS (Drug) $100.23
- Victoza (Drug) $99.00
- EUCRISA (Drug) $52.20
- VRAYLAR (Drug) $23.71
- REXULTI (Drug) $21.82
- Cologuard Collection Kit (Device) $14.86
- AFREZZA (Drug) $14.76
- Tymlos (Biological) $14.03
- GEMTESA (Drug) $13.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Alabaster
Ginger Alred, M.d, M.D
Internal Medicine — Payments: $882.64
Kimberly Forte, Md, MD
Internal Medicine — Payments: $206.59
Cynthia Walters, M.d, M.D
Internal Medicine — Payments: $199.53
Dr. Alvaro Garcia Arenas, Md, MD
Internal Medicine — Payments: $124.21
Nhan-Ai Le, M.d, M.D
Internal Medicine — Payments: $31.66
Madeline Bender, Md, MD
Internal Medicine — Payments: $16.20